Improving Quality Control: Tackling Residual DNA Testing In Biotherapy Manufacturing

Developing a compliant in-house assay for residual DNA can take years, requiring significant investment in time, resources, and specialized expertise. In contrast, commercial kits can dramatically reduce implementation timelines and lower risks. This presentation explores Thermo Fisher Scientific’s ResDNASEQ platform, a solution that exceeds regulatory expectations for sensitivity and is optimized for high DNA recovery.

Join expert Christian Reuter to discover how to implement an effective, cost-effective testing strategy in your manufacturing workflow. Watch the webinar to enhance your quality control processes.